Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 91
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT02147795 | The German Patient Blood Management Network | ||
| NCT01394562 | Effect of Ferric Carboxymaltose on Exercise Capacity in Patients With Iron Deficiency and Chronic Heart Failure | ||
| NCT03759964 | Effects of Ferinject® on Anemia and Transfusion Rates After Cardiac Surgery | ||
| NCT00706667 | Intravenous Ferric Carboxymaltose (Ferinject®) With or Without Erythropoietin in Patients Undergoing Orthopaedic Surgery | ||
| NCT02213653 | Randomized Study Evaluating Agents Stimulants Erythropoiesis (ASE) Associated With Ferric Carboxymaltose (Ferinject ®) in Concomitant or Sequential Patients Treated for Cancer and With Anemia Associated With Functional Iron Deficiency | ||
| NCT05136664 | Trial Evaluating the Efficacy and Safety of Patiromer in Chinese Subjects | ||
| NCT01913808 | Comparing Intravenous and Oral Iron in Postoperative Anemia | ||
| NCT06593392 | Safety and Tolerability of Difelikefalin in Adolescents on Haemodialysis With Moderate-to-Severe Pruritus | ||
| NCT01130597 | Evaluation of Patiromer Titration in Heart Failure Patients With Chronic Kidney Disease | ||
| NCT03214627 | Artificial Intelligence for Optimal Anemia Management in End-stage Renal Disease: The Anemia Control Model (ACM) Trial | ||
| NCT00821717 | EFfect of Ferric Carboxymaltose on exercIse CApacity and Cardiac Function in Patients With Iron deficiencY and Chronic Heart Failure | ||
| NCT04249648 | Hyperkalaemia and Its Impact on Therapy with RAASi | ||
| NCT01057004 | EVIdence Based TreAtment - Heart Failure (EVITA-HF) | ||
| NCT00810030 | FERINJECT for Correction of Anaemia in IBD Patients, FER-IBD-COR | ||
| NCT00810004 | Maintenance Treatment of Iron Deficiency in IBD Patients | ||
| NCT01810939 | A Two-Part, Single-Blind, Phase 3 Study Evaluating the Efficacy and Safety of Patiromer for the Treatment of Hyperkalemia (OPAL) | ||
| NCT02846896 | The Health Burden of Primary Biliary Cirrhosis (PBC) in Switzerland | ||
| NCT05514951 | Study of the Prevalence of Iron Deficiency in Elderly Patient in Hospital Environment | ||
| NCT02232906 | Switch From Oral Iron to Intravenous Ferric Carboxymaltose in Non-dialysis Chronic Kidney Disease (CKD) | ||
| NCT01477411 | A Drug-Drug Interaction Study of Digoxin and PA21 | ||
| NCT03010072 | The Effect of Phosphate Lowering Using Sucroferric Oxyhydroxide (PA21) on Calcification Propensity of Serum | ||
| NCT04938635 | Efficacy and Safety Study of Multiple Doses of VIT-2763 in Adults With Transfusion-dependent Beta-thalassemia | ||
| NCT02125344 | A Phase III Trial Comparing Two Dose-dense, Dose-intensified Approaches (ETC and PM(Cb)) for Neoadjuvant Treatment of Patients With High-risk Early Breast Cancer (GeparOcto) | ||
| NCT05460234 | RAYALDEE Non Interventional Study (NIS) on Effectiveness in ND-CKD SHPT Patients | ||
| NCT06256991 | Potassium Correction for RAAS Optimization in Chronic Kidney Disease | ||
| NCT04903717 | Pragmatic Trial Of Alerts for Use of Mineralocorticoid Receptor Antagonists | ||
| NCT00414128 | Clinical Trial of Mycophenolate Versus Cyclophosphamide in ANCA Vasculitis | ||
| NCT05389826 | mHealth for Phosphorus Management in CKD. | ||
| NCT05885737 | Phase 3 Study of Difelikefalin in Haemodialysis Chinese Adult Subjects With Moderate-to-Severe Pruritus | ||
| NCT01975272 | The Use of Iron Therapy for Patients With Anemia After Caesarean Section | ||
| NCT01131624 | Comparative Efficacy and Safety of Intravenous Ferric Carboxymaltose (FCM) Versus Oral Iron for Iron Deficiency Anaemia in Pregnant Women | ||
| NCT02243735 | Trial Comparing Ferric(III)Carboxymaltose Infusion With Oral Iron Suppletion as Treatment of Anaemia | ||
| NCT02221752 | Impact of Iron/Folic Acid vs Folic Acid Supplements During Pregnancy on Maternal and Child Health | ||
| NCT01345968 | Intravenous Ferric Carboxymaltose (Ferinject) in Patients Undergoing Orthopaedic Surgery | ||
| NCT00882414 | Ferinject® in Patient With Thrombocytosis Secondary to Inflammatory Bowel Disease (IBD) | ||
| NCT01288651 | Iron Deficiency In Pulmonary Hypertension | ||
| NCT01438359 | A Drug-Drug Interaction Study of Furosemide and PA21 | ||
| NCT02937454 | Study to Compare Ferric Carboxymaltose With Placebo in Patients With Acute Heart Failure and Iron Deficiency | ||
| NCT03769441 | Effect of Ferric Carboxymaltose on Exercise Capacity After Kidney Transplantation | ||
| NCT01324752 | A Drug-Drug Interaction Study of Losartan and PA21 | ||
| NCT05524467 | Cross-sectional Study to Assess Prevalence and Burden of CKD-associated Pruritus in Haemodialysis Patients | ||
| NCT01453608 | A Study to Compare the Use of Ferric Carboxymaltose With Placebo in Patients With Chronic Heart Failure and Iron Deficiency | ||
| NCT04806048 | Feasibility of Implementation of Recommended Standards in Patients With Heart Failure | ||
| NCT03888066 | Patiromer for the Management of Hyperkalemia in Subjects Receiving RAASi Medications for the Treatment of Heart Failure (DIAMOND) | ||
| NCT05034250 | Iron Status in Female Infertility and Recurrent Miscarriage | ||
| NCT03781089 | Patiromer Efficacy to Reduce Episodic Hyperkalemia in End Stage Renal Disease Patients | ||
| NCT01513369 | Ferric Carboxymaltose in Type 2 Diabetes Mellitus (T2DM) Patients With Iron Deficiency | ||
| NCT05861492 | FDDA Utilization Study (FDDAU) | ||
| NCT06434025 | IV Iron and SGLT2 Inhibitor on Ventricular Function and Myocardial Iron Content in Heart Failure With Iron Deficiency | ||
| NCT02033317 | An Open-Label, Multiple Dose Study to Evaluate the Pharmacology, Safety, and Tolerability of Patiromer in Participants on Hemodialysis |
